CO5251448A1 - Soluciones que contienen epinastina - Google Patents
Soluciones que contienen epinastinaInfo
- Publication number
- CO5251448A1 CO5251448A1 CO00085787A CO00085787A CO5251448A1 CO 5251448 A1 CO5251448 A1 CO 5251448A1 CO 00085787 A CO00085787 A CO 00085787A CO 00085787 A CO00085787 A CO 00085787A CO 5251448 A1 CO5251448 A1 CO 5251448A1
- Authority
- CO
- Colombia
- Prior art keywords
- containing epinastine
- solution
- solution according
- possibly
- solutions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
- F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
- F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
- F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T137/00—Fluid handling
- Y10T137/0318—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
Abstract
Solución acuosa aplicable por vía tópica que contiene epinastina, eventualmente en forma de su racemato, sus enantiómeros, así como eventualmente en forma de sus sales por adición de ácidos farmacológicamente inocuas, en una concentración de 0,005 a 0,5 mg/ml de solución. Solución según la reivindicación 1 que contiene hidrocloruro de epinastina. Solución según una de las reivindicaciones 1 ó 2, caracterizada porque es ajustada a un valor del pH comprendido entre 6,5 y 7,2 mediante un tampón fisiológicamente compatible. Solución según la reivindicación 3, caracterizada porque contiene además un agente de conservación. Utilización de una de las soluciones según una de las reivindicaciones 1 a 4 para la inhibición de la afluencia de neutrófilos y eosinófilos en el tejido de Ia conjuntiva del ojo o en el de la mucosa nasal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19954516A DE19954516A1 (de) | 1999-11-12 | 1999-11-12 | Epinastin-haltige Lösungen |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5251448A1 true CO5251448A1 (es) | 2003-02-28 |
Family
ID=7928843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00085787A CO5251448A1 (es) | 1999-11-12 | 2000-11-10 | Soluciones que contienen epinastina |
Country Status (40)
Country | Link |
---|---|
US (6) | US20030050303A1 (es) |
EP (1) | EP1231920B1 (es) |
JP (1) | JP2003514021A (es) |
KR (1) | KR100758842B1 (es) |
CN (1) | CN1292752C (es) |
AR (1) | AR026424A1 (es) |
AT (1) | ATE353218T1 (es) |
AU (2) | AU784017B2 (es) |
BG (1) | BG65775B1 (es) |
BR (1) | BR0015477A (es) |
CA (1) | CA2391076C (es) |
CO (1) | CO5251448A1 (es) |
CY (1) | CY1106375T1 (es) |
CZ (1) | CZ302483B6 (es) |
DE (2) | DE19954516A1 (es) |
DK (1) | DK1231920T3 (es) |
EA (1) | EA006937B1 (es) |
EE (1) | EE05395B1 (es) |
ES (1) | ES2281359T3 (es) |
HK (1) | HK1052303B (es) |
HR (1) | HRP20020404B1 (es) |
HU (1) | HU229502B1 (es) |
IL (2) | IL149501A0 (es) |
ME (1) | MEP36708A (es) |
MX (1) | MXPA02004556A (es) |
MY (1) | MY130441A (es) |
NO (1) | NO329417B1 (es) |
NZ (1) | NZ519425A (es) |
PE (1) | PE20010826A1 (es) |
PL (1) | PL198879B1 (es) |
PT (1) | PT1231920E (es) |
RS (1) | RS50173B (es) |
SA (1) | SA01210658B1 (es) |
SI (1) | SI1231920T1 (es) |
SK (1) | SK287343B6 (es) |
TR (1) | TR200201270T2 (es) |
TW (1) | TWI225401B (es) |
UA (1) | UA74563C2 (es) |
WO (1) | WO2001035962A1 (es) |
ZA (1) | ZA200203683B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
CA2494065A1 (en) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
EP1468696A1 (en) * | 2003-04-17 | 2004-10-20 | Boehringer Ingelheim International GmbH | Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
CN101217948A (zh) * | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
WO2008098122A2 (en) * | 2007-02-08 | 2008-08-14 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
US20080194544A1 (en) * | 2007-02-08 | 2008-08-14 | Ramesh Krishnamoorthy | Aqueous formulations of epinastine for treating allergic rhinitis |
US7378082B1 (en) | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
EP2464387A4 (en) * | 2009-08-12 | 2013-05-15 | Seros Medical Llc | DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE |
TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
EP2630952A1 (en) * | 2012-02-23 | 2013-08-28 | Novagali Pharma S.A. | Self-preserved oil dispersions comprising boric acid |
BR112015014367B1 (pt) * | 2012-12-19 | 2022-11-22 | Novartis Ag | Composição inibidora de lfa-1, método para estabilizar a dita composição e uso da mesma para tratar uma doença ocular |
CN104491876A (zh) * | 2014-12-23 | 2015-04-08 | 中国药科大学 | 含玻璃酸钠的依匹斯汀滴眼液及其制备方法 |
ITUB20153950A1 (it) * | 2015-09-28 | 2017-03-28 | Tred Srl | Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea |
JP6134853B1 (ja) * | 2016-10-28 | 2017-05-24 | 参天製薬株式会社 | エピナスチン含有点眼液 |
JP6635974B2 (ja) * | 2017-04-24 | 2020-01-29 | 参天製薬株式会社 | エピナスチン含有点眼液 |
KR102582048B1 (ko) * | 2017-05-01 | 2023-09-21 | 산텐 세이야꾸 가부시키가이샤 | 점안제 |
JP2019108320A (ja) * | 2018-10-31 | 2019-07-04 | 参天製薬株式会社 | ソフトコンタクトレンズの変質を抑制する眼科用組成物 |
JP6736752B2 (ja) * | 2019-12-17 | 2020-08-05 | 参天製薬株式会社 | エピナスチン含有点眼液 |
JP7118579B1 (ja) | 2020-04-16 | 2022-08-16 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
JP6963651B2 (ja) * | 2020-04-16 | 2021-11-10 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性組成物 |
JP2020169213A (ja) * | 2020-07-15 | 2020-10-15 | 参天製薬株式会社 | エピナスチン含有点眼液 |
CN115448927A (zh) * | 2022-10-20 | 2022-12-09 | 重庆瑞泊莱医药科技有限公司 | 一种氢溴酸依匹斯汀晶型ii及其制备方法 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US104017A (en) * | 1870-06-07 | Improvement in embroidering attachment for sewing-machines | ||
US181478A (en) * | 1876-08-22 | Improvement in water-wheels | ||
US8632A (en) * | 1852-01-06 | George hess | ||
US203021A (en) * | 1878-04-30 | Improvement in side-bar wagons | ||
US215396A (en) * | 1879-05-13 | Improvement in loom-temples | ||
US228359A (en) * | 1880-06-01 | jones | ||
US151541A (en) * | 1874-06-02 | Improvement in hay-loaders | ||
DE3008944A1 (de) * | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Dibenzimidazoazepine, ihre herstellung und verwendung |
DE4102148A1 (de) * | 1991-01-25 | 1992-07-30 | Boehringer Ingelheim Kg | Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid |
US5668133A (en) * | 1992-12-09 | 1997-09-16 | Alcon Laboratories, Inc. | Ophthalmic compositions comprising emedastine and methods for their use |
IL122752A (en) * | 1995-06-27 | 2001-07-24 | Boehringer Ingelheim Kg | Stable preparations for creating propellant-free sprays |
DE19542281C2 (de) * | 1995-11-14 | 1997-12-04 | Boehringer Ingelheim Kg | Verwendung von Epinastin für die Behandlung der Migräne |
JP3124041B2 (ja) * | 1996-08-30 | 2001-01-15 | 京都薬品工業株式会社 | アレルギー性皮膚炎治療剤 |
US20030215396A1 (en) * | 1999-09-15 | 2003-11-20 | Boehringer Ingelheim Pharma Kg | Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
EP0903151A1 (en) * | 1997-09-22 | 1999-03-24 | ASTA Medica Aktiengesellschaft | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
DE19954516A1 (de) | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
CN1376066A (zh) * | 1999-11-18 | 2002-10-23 | 爱尔康公司 | H1拮抗剂和安全类固醇的治疗眼病的用途 |
DE19958460A1 (de) * | 1999-12-03 | 2001-06-07 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation |
FR2803520B1 (fr) * | 2000-01-12 | 2002-09-20 | Ceva Sante Animale | Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles |
US20020094345A1 (en) * | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
US20020151541A1 (en) * | 2000-10-31 | 2002-10-17 | Michel Pairet | Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |
US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
DE10119718A1 (de) * | 2001-04-21 | 2002-10-31 | Boehringer Ingelheim Pharma | Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff |
AU2002305780A1 (en) * | 2001-05-29 | 2002-12-09 | Transchip, Inc. | Patent application cmos imager for cellular applications and methods of using such |
US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
EP1350512A1 (en) * | 2002-04-03 | 2003-10-08 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
US6863848B2 (en) * | 2002-08-30 | 2005-03-08 | Signet Armorlite, Inc. | Methods for preparing composite photochromic ophthalmic lenses |
JP2007145316A (ja) * | 2005-10-27 | 2007-06-14 | Nissan Motor Co Ltd | 遮光装置とサンバイザーとサンルーフユニット |
-
1999
- 1999-11-12 DE DE19954516A patent/DE19954516A1/de not_active Withdrawn
-
2000
- 2000-10-14 WO PCT/EP2000/010122 patent/WO2001035962A1/de active IP Right Grant
- 2000-10-14 EE EEP200200246A patent/EE05395B1/xx unknown
- 2000-10-14 ME MEP-367/08A patent/MEP36708A/xx unknown
- 2000-10-14 MX MXPA02004556A patent/MXPA02004556A/es active IP Right Grant
- 2000-10-14 PT PT00972763T patent/PT1231920E/pt unknown
- 2000-10-14 UA UA2002064760A patent/UA74563C2/uk unknown
- 2000-10-14 TR TR2002/01270T patent/TR200201270T2/xx unknown
- 2000-10-14 NZ NZ519425A patent/NZ519425A/en not_active IP Right Cessation
- 2000-10-14 ES ES00972763T patent/ES2281359T3/es not_active Expired - Lifetime
- 2000-10-14 DK DK00972763T patent/DK1231920T3/da active
- 2000-10-14 EA EA200200492A patent/EA006937B1/ru not_active IP Right Cessation
- 2000-10-14 JP JP2001537955A patent/JP2003514021A/ja active Pending
- 2000-10-14 BR BR0015477-6A patent/BR0015477A/pt not_active Application Discontinuation
- 2000-10-14 IL IL14950100A patent/IL149501A0/xx unknown
- 2000-10-14 AT AT00972763T patent/ATE353218T1/de active
- 2000-10-14 PL PL364028A patent/PL198879B1/pl unknown
- 2000-10-14 HU HU0203773A patent/HU229502B1/hu unknown
- 2000-10-14 CZ CZ20021956A patent/CZ302483B6/cs not_active IP Right Cessation
- 2000-10-14 CA CA002391076A patent/CA2391076C/en not_active Expired - Lifetime
- 2000-10-14 RS YUP-336/02A patent/RS50173B/sr unknown
- 2000-10-14 CN CNB00815547XA patent/CN1292752C/zh not_active Expired - Lifetime
- 2000-10-14 AU AU11381/01A patent/AU784017B2/en not_active Expired
- 2000-10-14 SK SK830-2002A patent/SK287343B6/sk not_active IP Right Cessation
- 2000-10-14 SI SI200030938T patent/SI1231920T1/sl unknown
- 2000-10-14 DE DE50014041T patent/DE50014041D1/de not_active Expired - Lifetime
- 2000-10-14 KR KR1020027006058A patent/KR100758842B1/ko active IP Right Grant
- 2000-10-14 EP EP00972763A patent/EP1231920B1/de not_active Expired - Lifetime
- 2000-11-10 TW TW089123815A patent/TWI225401B/zh not_active IP Right Cessation
- 2000-11-10 PE PE2000001201A patent/PE20010826A1/es not_active Application Discontinuation
- 2000-11-10 CO CO00085787A patent/CO5251448A1/es not_active Application Discontinuation
- 2000-11-10 MY MYPI20005284A patent/MY130441A/en unknown
- 2000-11-10 AR ARP000105932A patent/AR026424A1/es not_active Suspension/Interruption
-
2001
- 2001-01-20 SA SA01210658A patent/SA01210658B1/ar unknown
-
2002
- 2002-05-07 IL IL149501A patent/IL149501A/en active IP Right Grant
- 2002-05-08 NO NO20022201A patent/NO329417B1/no not_active IP Right Cessation
- 2002-05-09 HR HR20020404A patent/HRP20020404B1/xx not_active IP Right Cessation
- 2002-05-09 ZA ZA200203683A patent/ZA200203683B/xx unknown
- 2002-05-09 BG BG106681A patent/BG65775B1/bg unknown
- 2002-10-15 US US10/271,180 patent/US20030050303A1/en not_active Abandoned
-
2003
- 2003-06-30 HK HK03104651.9A patent/HK1052303B/zh not_active IP Right Cessation
-
2005
- 2005-08-30 US US11/215,165 patent/US20050288274A1/en not_active Abandoned
-
2006
- 2006-04-12 AU AU2006201541A patent/AU2006201541A1/en not_active Abandoned
-
2007
- 2007-03-13 CY CY20071100351T patent/CY1106375T1/el unknown
- 2007-04-12 US US11/734,512 patent/US20070185082A1/en not_active Abandoned
- 2007-04-12 US US11/734,507 patent/US20070197503A1/en not_active Abandoned
- 2007-09-27 US US11/863,008 patent/US7429602B2/en not_active Expired - Lifetime
-
2009
- 2009-02-27 US US12/394,684 patent/US20090239842A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5251448A1 (es) | Soluciones que contienen epinastina | |
CO5190689A1 (es) | Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales | |
AR102101A2 (es) | Formulación y método de complejo de aripiprazol | |
BRPI0407845A (pt) | formulação intranasal de rotigotina | |
BRPI0014869B8 (pt) | prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização | |
ATE273033T1 (de) | Stabilisierte ophthalmische wasserstoffperoxidlösung | |
AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
ATA2332000A (de) | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung | |
AR034817A1 (es) | Barra de detergente mejorada y procedimiento de fabricacion | |
PE20010127A1 (es) | Suspension de ziprasidona | |
AR039977A1 (es) | Composicion a base de diclofenac para el tratamiento topico de afecciones de la cavidad orofaringea | |
CO5611150A2 (es) | Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion | |
AR041069A1 (es) | Composicion de tolterodina liquida oral | |
AR047438A1 (es) | Sal amina de derivado de carboestirilo | |
AR033312A1 (es) | Composicion que consta de un agonista alfa-2 adrenergico y un acido graso | |
AR043536A1 (es) | Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico | |
BR0013651A (pt) | Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados | |
AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
ES2181415T3 (es) | Composicion acuosa ionica que contiene levomentol. | |
AR044697A1 (es) | Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato | |
TR200000890T2 (tr) | Topik ilacın üretilmesi için -amino levülozik asidin kullanılması | |
PE20040067A1 (es) | Nueva formulacion para la administracion parenteral de crobenetina | |
AR040001A1 (es) | Formulaciones de bisfosfonatos de uso inyectable | |
UY26432A1 (es) | Soluciones que contienen epinastina | |
RU2000105080A (ru) | Препарат для лечения гриппа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |